Galectin signature in normal pregnancy and preeclampsia

Journal of Reproductive Immunology

Volumn 101-102, Issue 1, 2014, Pages 127-134

  Blois, Sandra M ^a   Barrientos, Gabriela ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Angiogenesis; Galectins; Placentation; Preeclampsia

Indexed keywords

GALECTIN;

ARTICLE; DECIDUA; HUMAN; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION;

ANGIOGENESIS; GALECTINS; PLACENTATION; PREECLAMPSIA;

DECIDUA; FEMALE; GALECTINS; GENE EXPRESSION REGULATION; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; TRANSCRIPTOME;

EID: 84897640129     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.05.005     Document Type: Article

References (87)

1. Alves C.M., et al. Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early toxoplasma gondii infection. Immunobiology 2010, 215:475-485.
2. Balogh A., et al. Placental protein 13 (pp13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol. 2011, 205(15):e1-e14.
3. Barondes S.H., et al. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 1994, 269:20807-20810.
4. Blois S.M., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
5. Brewer C.F., et al. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 2002, 12:616-623.
6. Camby I., et al. Galectin-1: a small protein with major functions. Glycobiology 2006, 16:137R-157R.
7. Carlino C., et al. Recruitment of circulating nk cells through decidual tissues: a possible mechanism controlling nk cell accumulation in the uterus during early pregnancy. Blood 2008, 111:3108-3115.
8. Cattaneo V., et al. Galectin-8 tandem-repeat structure is essential for t-cell proliferation but not for co-stimulation. Biochem. J. 2011, 434:153-160.
9. Chen H.Y., et al. Roles of galectin-3 in immune responses. Arch. Immunol. Ther. Exp. 2005, 53:497-504.
10. Choe Y.S., et al. Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. Mol. Reprod. Dev. 1997, 48:261-266.
11. Cindrova-Davies T., et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am. J. Pathol. 2007, 171:1168-1179.
12. Colnot C., et al. Embryonic implantation in galectin 1/galectin 3 double mutant mice. Dev. Dyn. 1998, 211:306-313.
13. Cooper D.N. Galectinomics: finding themes in complexity. Biochim. Biophys. Acta 2002, 1572:209-231.
14. Cordo-Russo R.I., et al. HA in pathological and physiological processes: An overview of HA metabolism in cancer and pregnancy. Curr. Trend. in Immunol 2012, 13:81-94.
15. Crider-Pirkle S., et al. Cubilin, a binding partner for galectin-3 in the murine utero-placental complex. J. Biol. Chem. 2002, 277:15904-15912.
16. Delgado V.M., et al. Modulation of endothelial cell migration and angiogenesis: a novel function for the Tandem-repeat Lectin galectin-8. FASEB J. 2011, 25:242-254.
17. Dong M., et al. The effect of trophoblasts on t lymphocytes: possible regulatory effector molecules - a proteomic analysis. Cell. Physiol. Biochem. 2008, 21:463-472.
18. Douglas N.C., et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology 2009, 150:3845-3854.
19. Eshkar Sebban L., et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J. Immunol. 2007, 179:1225-1235.
20. Farina A., et al. Performance of messenger rNAS circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. Am. J. Obstet. Gynecol. 2010, 203(57):e1-e7.
21. Froehlich R., et al. Galectin fingerprinting detects differences in expression profiles between bovine endometrium and placentomes as well as early and late gestational stages. Placenta 2012, 33:195-201.
22. Gizurarson S., et al. Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents. Fetal Diagn. Ther. 2013, 33:257-264.
23. Halder J.B., et al. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 2000, 26:213-224.
24. Harskamp R.E., Zeeman G.G. Preeclampsia: at risk for remote cardiovascular disease. Am. J. Med. Sci. 2007, 334:291-295.
25. Hernandez J.D., Baum L.G. Ah sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002, 12:127R-136R.
26. Herse F., et al. Cytochrome p450 subfamily 2j polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. Circulation 2012, 126:2990-2999.
27. Heusschen R., et al. Profiling lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy. Biol. Reprod. 2013, 88:22.
28. Hirota Y., et al. Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin fkbp52. Endocrinology 2012, 153:2486-2493.
29. Hsieh S.H., et al. Galectin-1 a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 2008, 27:3746-3753.
30. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008, 51:970-975.
31. Huppertz B., et al. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum. Reprod. Update 2013, 19:391-405.
32. Iglesias M.M., et al. Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance. Glycobiology 1998, 8:59-65.
33. Jeschke U., et al. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal IUGR, preeclamptic and HELLP placentas. Placenta 2007, 28:1165-1173.
34. Kliman H.J., et al. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia. Reprod. Sci. 2012, 19:16-30.
35. Kolundzic N., et al. Galectin-1 is part of human trophoblast invasion machinery - a functional study in vitro. PLoS ONE 2011, 6:e28514.
36. Kolundzic N., et al. Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta. Placenta 2011, 32:909-911.
37. Koopman L.A., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003, 198:1201-1212.
38. Kopcow H.D., et al. T cell apoptosis at the maternal-fetal interface in early human pregnancy involvement of galectin-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18472-18477.
39. Kuang H., et al. Hormonal regulation of uterine natural killer cells in mouse preimplantation uterus. J. Mol. Histol. 2010, 41:1-7.
40. Lindheimer M.D., et al. Ash position paper: hypertension in pregnancy. J. Clin. Hypertens. (Greenwich) 2009, 11:214-225.
41. Liu A.X., et al. Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. Biol. Reprod. 2006, 75:414-420.
42. Liu F.T., et al. Intracellular functions of galectins. Biochim. Biophys. Acta 2002, 1572:263-273.
43. Maquoi E., et al. Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 1997, 18:433-439.
44. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
45. Molvarec A., et al. Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia. Clin. Immunol. 2011, 139:48-56.
46. Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 2005, 6:607-614.
47. Nicolaides K.H., et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet. Gynecol. 2006, 27:13-17.
48. Nishi N., et al. Galectin-8 modulates neutrophil function via interaction with integrin alpham. Glycobiology 2003, 13:755-763.
49. Ogawa M., et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta 2007, 28:224-232.
50. Oomizu S., et al. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but TIM-3-independent manner. Clin. Immunol. 2012, 143:51-58.
51. Phillips B., et al. Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice. Biol. Reprod. 1996, 55:548-558.
52. Popovici R.M., et al. Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. J. Clin. Endocrinol. Metab. 2005, 90:6170-6176.
53. Powe C.E., et al. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011, 123:2856-2869.
54. Rabinovich G.A., et al. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand. J. Immunol. 2007, 66:143-158.
55. Redman C.W. Immunological aspects of pre-eclampsia. Baillieres Clin. Obstet. Gynaecol. 1992, 6:601-615.
56. Redman C.W., Sargent I.L. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008, 29(Suppl A):S73-S77.
57. Redman C.W., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta 2009, 30(Suppl A):S38-S42.
58. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:534-543.
59. Redman C.W., et al. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 1999, 180:499-506.
60. Sammar M., et al. Placenta-bound and body fluid PP13 and its MRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery. Placenta 2011, 32(Suppl):S30-S36.
61. Sargent I.L., et al. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod. Biomed. Online 2007, 14(Spec No. 1):111-117.
62. Sekizawa A., et al. PP13 MRNA expression in trophoblasts from preeclamptic placentas. Reprod. Sci. 2009, 16:408-413.
63. Shimizu H., et al. PP13 MRNA expression in the cellular component of maternal blood as a marker for preeclampsia. Prenat. Diagn. 2009, 29:1231-1236.
64. Sibai B.M., et al. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am. J. Obstet. Gynecol. 1991, 165:1408-1412.
65. Sibai B.M. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin. Perinatol. 2006, 30:16-19.
66. Staff A.C., et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension 2013, 61:932-942.
67. Stillman B.N., et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce t cell death. J. Immunol. 2006, 176:778-789.
68. Than N.G., et al. Isolation and sequence analysis of a cdna encoding human placental tissue protein 13 (pp13) a new lysophospholipase, homologue of human eosinophil charcot-leyden crystal protein. Placenta 1999, 20:703-710.
69. Than N.G., et al. Functional analyses of placental protein 13/galectin-13. Eur. J. Biochem. 2004, 271:1065-1078.
70. Than N.G., et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch. 2008, 453:387-400.
71. Than N.G., et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J. Matern. Fetal Neonatal Med. 2008, 21:429-442.
72. Than N.G., et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9731-9736.
73. Thijssen V.L., et al. The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am. J. Pathol. 2008, 172:545-553.
74. Thijssen V.L., et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 2010, 70:6216-6224.
75. Tirado-Gonzalez I., et al. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy. Mol. Hum. Reprod. 2013, 19:43-53.
76. Tribulatti M.V., et al. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of t cell responses. J. Immunol. 2012, 188:2991-2999.
77. Vicovac L., et al. Galectin-1 and -3 in cells of the first trimester placental bed. Hum. Reprod. 1998, 13:730-735.
78. Vince G.S., et al. Interleukin-6 tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 1995, 102:20-25.
79. Von Dadelszen P., et al. Subclassification of preeclampsia. Hypertens Pregnancy 2003, 22:143-148.
80. Von Wolff M., et al. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol. Hum. Reprod. 2005, 11:189-194.
81. Wortelboer E.J., et al. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 2010, 117:1384-1389.
82. Yamamoto H., et al. Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells. J. Biochem. 2008, 143:311-324.
83. Yang H., et al. Expression of galectin-3 in mouse endometrium and its effect during embryo implantation. Reprod. Biomed. Online 2012, 24:116-122.
84. Yang R.Y., et al. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6737-6742.
85. Zhao X.Y., et al. Synergistic induction of galectin-1 by ccaat/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J. Biol. Chem. 2011, 286:36808-36819.
86. Zhu C., et al. TIM-3 and its regulatory role in immune responses. Curr. Top. Microbiol. Immunol. 2011, 350:1-15.
87. Zick Y., et al. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj. J. 2004, 19:517-526.